A recent study using K-Ras–initiated lung tumors showed that ZEB1-induced EMT is linked to immunotherapy resistance by increasing the expression of PD-L1 and CD47 by cancer cells, and then driving the polarization of adjacent TAMs into immunosuppressive M2 macrophages [163]. This evidence concerns the gene ZEB1 and cancer.